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A B S T R A C T   
Very little is known about the experience of people living with Parkinson’s disease (PD) in low- and middle- 
income countries, such as those in sub-Saharan Africa. The number of specialists in the region is low and 
awareness is limited among the population and healthcare professionals. Drawing on ten months of ethnographic 
fieldwork in urban and rural Kenya with 55 people living with PD (PwP), 23 family members and 22 healthcare 
professionals from public and private clinics, we set out to understand the experience of diagnosis among PwP in 
Kenya. The diagnostic journeys of our study participants were typically long, convoluted and confusing. Lack of 
relevant information, combined with comorbidities and expectations about ‘normal’ ageing, often conspired to 
delay interactions with health services for many. There often followed an extended period of diagnostic un-
certainty, misdiagnosis and even ‘undiagnosis’, where a diagnostic decision was reversed. Following diagnosis, 
patients continued to lack information about their condition and prognosis, making it difficult for friends, family 
members and others to understand what was happening to them. We suggest that awareness of PD and its 
symptoms needs to improve among the general population and healthcare professionals. However, diagnosis is 
only the first step, and needs to be accompanied by better access to information, affordable treatment and 
support.   
1. Introduction 
Parkinson’s disease (PD) is one of most common neurodegenerative 
diseases globally yet is almost entirely absent from “global health” 
policy discourse and research, especially in low- and middle-income 
countries (LMICs). PD is associated with motor symptoms, including 
tremor, muscular rigidity (stiffness), slowness of movement, loss of 
spontaneous voluntary movement and balance issues (DeMaagd and 
Philip, 2015). Non-motor complications (some of which may present 
several years before onset of motor symptoms) include depression, 
anxiety, apathy, cognitive dysfunction, pain, sleep disturbances, and 
incontinence, among others. PD is a progressive condition, so medica-
tion cannot alter the course of the disease. However, symptomatic drug 
therapy is effective in improving motor symptoms as well as quality and 
length of life. 
Several PD prevalence studies have been carried out globally yet, as 
Okubadejo et al. (2006) and Dekker et al. (2020) have noted, data on 
prevalence in sub-Saharan Africa remains extremely limited. Existing 
prevalence estimates range from 7 per 100,000 population in Ethiopia 
(Tekle-Haimanot, 1985) to 40 per 100,000 in Tanzania (age-standar-
dised to the UK) (Dotchin et al., 2008). These estimates are generally 
lower than those in high-income countries (HICs), e.g. a prevalence of 
667/100,000 in males over 45-years-old in the USA (Marras et al., 
2018), but a lack of diagnostic capacity in LMICs (as we discuss below) 
means that these are almost certainly under-estimates. Moreover, as a 
condition associated with later life, the prevalence of PD is set to rise 
across SSA and other regions of the world as life expectancy continues to 
improve (United Nations, 2019). Dorsey and Bloem (2018) warn of an 
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imminent “Parkinson Pandemic”, with the number of people living with 
PD globally projected to rise from 6.2 million currently to a conservative 
estimate of 12.9 million by 2040. 
Sub-Saharan Africa, and other lower-income regions of the world, 
are ill-prepared to manage this situation, with diagnostic and treatment 
capacity lagging far behind most HICs (Dotchin et al., 2007; Dorsey and 
Bloem, 2018). Although prevalence is almost certainly rising, PD re-
mains a largely unknown condition across Africa, and people experi-
encing symptoms associated with PD often face considerable social 
stigma and lack access to biomedical treatment due to misdiagnoses and 
financial barriers to healthcare (Mshana et al., 2011; Kaddumukasa 
et al., 2015; Mokaya et al., 2017; Walga, 2019). 
A lack of specialist neurological services across the continent makes 
diagnosis challenging (Dotchin et al., 2007), while PD treatment is often 
unavailable or unaffordable (Mokaya et al., 2016; Okubadejo et al., 
2019). Early diagnosis and effective treatment can delay onset of severe 
symptoms, thereby increasing both length and quality of life and 
reducing the burden of care on family members (Dotchin et al., 2014). In 
Tanzania, Mshana et al. (2011) found that barriers to diagnosis and 
treatment resulted in PwP experiencing emotional, psychological and 
physical difficulties, reducing their, and their caregivers, quality of life. 
Understanding the challenges that people with Parkinson’s disease 
(PwP), their families and healthcare professionals face in diagnosing and 
managing PD in resource-constrained settings is therefore crucial; 
however, we currently know very little about how PwP access, and 
interact with, healthcare services in LMIC settings or how they negotiate 
life with PD. 
This paper focuses on the first pre-requisite to managing PD effec-
tively: obtaining a timely and reliable diagnosis. We know from earlier 
studies (Okubadejo et al., 2006; Dotchin et al., 2007, 2008; Dotchin and 
Walker, 2012), that many – probably most – PwP in SSA are not diag-
nosed and, if they are, diagnosis is usually delayed. Delayed diagnosis is 
not exclusive to LMICs: in some HICs, PwP are reported to delay seeking 
care for some time after onset of symptoms (Schrag et al., 2018), and this 
may be particularly true for under-served sectors of the population (for 
example, African-American and Latino populations; see Dahodwala 
et al. (2009)). However, given the lack of specialist services, this is likely 
to be a very significant issue in Africa and other lower-income regions. 
We report below on a qualitative, ethnographic study on the expe-
riences of Parkinson’s disease in Kenya, an East African country with 
relatively good levels of healthcare provision compared with other 
countries in the region. The specific focus is on understanding how 
people negotiate what is typically a long and convoluted diagnostic 
process. More generally, this study also contributes to the small but 
growing literature on PD and ageing in Africa. Drawing on concepts and 
theories derived from studies on other chronic conditions in SSA, we 
situate the findings within ideas and expectations around ageing, 
“personhood” (Degnen, 2018) and “interdependence” in later life 
(McIntosh, 2017); chronic and existential “uncertainty” (Whyte, 2009); 
and the role of “biolegitimacy” (Fassin, 2009) in making sense of the 
condition. However, as we shall see, PD diverges in some important 
ways from some other, ‘higher-profile’ chronic conditions (HIV/AIDS 
and diabetes, for example), owing not least to its relative political 
invisibility and its inevitably progressive nature. 
1.1. Research setting and background 
This study was conducted across multiple sites in Kenya, a lower- 
middle-income country situated on Africa’s east coast. As of 2018, 
34.4% of Kenyans were living in extreme poverty (World Bank, 2019). 
Although poverty rates are higher in rural Kenya (40%) compared to 
urban areas (29%) (Diwakar and Shepherd, 2018), 70% of residents in 
the capital city, Nairobi, live in slums and informal settlements (APHRC, 
2014). Older people living in slums are becoming increasingly vulner-
able because of weakening support networks, ill health, poor access to 
health facilities and lack of pension support (Wilunda et al., 2015; 
Wairiuko et al., 2017). During the years 2017–2019, 11.3% of the 
working-age Kenyan population (aged 15–64) were actively contrib-
uting to a pension scheme (ILO, 2018). 
1.2. Epidemiological profile 
Kenya has seen significant improvements in life expectancy (66 years 
in 2017) since the turn of the century (51 years in 2000) (United Na-
tions, 2019), associated with significant reductions in maternal and 
child mortality, and action on major infectious diseases (especially 
malaria, tuberculosis, HIV) in line with Millennium Development Goal 
targets (United Nations, 2008). However, as with many LMICs, an 
increasing ageing population coupled with significant ‘lifestyle shifts’ 
has been associated with a rising prevalence of non-communicable 
diseases (NCDs) and, often, multiple co-morbidities, placing significant 
new pressures on health services (Bigna and Noubiap, 2019). In 2018, 
NCDs accounted for 50% of inpatient admissions in Kenyan public fa-
cilities and 40% of hospital deaths (Onyango and Onyango, 2018). 
1.3. Healthcare services and associated costs 
PD cannot be ‘cured’, but effective management under neurologists 
and geriatricians (with specialisation in movement disorders) can slow 
progression and improve quality of life. However, clinical capacity in 
these areas is very limited across the African continent (Dotchin et al., 
2013; Bower et al., 2014). Kenya is among the better served African 
countries in this respect, with numbers increasing in recent years, but it 
still has fewer than 20 neurologists, all of whom are located in three 
major cities (Fothergill-Misbah et al., 2020a). 
Capacity in Kenya is particularly limited in the public sector (WHO, 
2019). The main national referral hospital in Nairobi holds Kenya’s only 
public neurology clinic, yet it is chronically understaffed (The National 
Assembly, 2019); overwhelmed clinics mean that registrars with limited 
specialist training often run outpatient clinics with little or no supervi-
sion. Outside the capital city, there is no public-sector provision at all for 
PD. The private healthcare sector in Kenya is one of the most 
highly-developed in Africa (Barnes et al., 2010) yet, as noted above, 
treatment is only available in the three major cities. Even for those living 
within reach of a hospital offering appropriate treatment, user consul-
tation costs can be prohibitive. As of 2019, public clinic fees were $6 
while private fees could reach $300 – completely unaffordable for 90% 
of Kenyans (Prince, 2018). Mokaya et al. (2016) determined that, based 
on a monthly minimum wage in Kenya of 11,222Ksh ($100), individuals 
have 7% of their net salary (or $9) left for healthcare costs every month 
after basic living expenses. However, with the informal sector ac-
counting for more than 80% of Kenya’s workforce (Okungu and McIn-
tyre, 2019), most do not receive minimum wage. 
This situation is compounded by low coverage of health insurance in 
Kenya (19% of the population) (Barasa et al., 2018), with flat-rate 
contributions and default penalties deterring informal workers from 
enrolling (Barasa et al., 2017). Consequently, out-of-pocket payments 
for healthcare drove 1.1 million individuals into poverty in 2018, with 
older people, those affected by chronic disease and people regularly 
accessing outpatient services disproportionately affected (Salari et al., 
2019). 
Against this background, we sought to understand how PwP in Kenya 
go about trying to obtain a diagnosis and what challenges they 
encounter along the way. 
2. Methods 
The data presented here come from a larger ethnographic study 
exploring the lived experience of PwP, and their families, in Kenya. The 
lead author conducted ten months of ethnographic fieldwork in Kenya 
(March 2018–December 2018 and May 2019), involving participant 
observation, in-depth semi-structured interviews and informal 
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conversations with PwP, family members and healthcare professionals. 
An ethnographic approach enabled a holistic and in-depth understand-
ing of how PwP and their families lived with, and managed, PD in a 
resource-constrained setting characterised by uncertainty and 
improvisation. 
2.1. Participants and study sites 
The majority of fieldwork was conducted in two major cities, Nairobi 
and Mombasa, with shorter periods of study in rural settings (seven days 
in rural central Kenya and two days in Western Kenya) to understand 
what services outside of neurology were available. Fifty-five PwP were 
recruited from: two private neurology clinics (one in Nairobi (N = 9) and 
one in Mombasa (N = 16)); one public neurology clinic in Nairobi (N =
12); and a PD support group in Nairobi (N = 18). Of the 55, 39 PwP lived 
in urban areas, while 16 lived in rural Kenya and had travelled to Nai-
robi or Mombasa for diagnosis and follow-up. The sample is heavily 
skewed towards urban residents by necessity: neurology clinics and 
support groups are available only in the major cities and are unreachable 
for most rural Kenyans. The only rural residents in the sample were 
those with sufficient resources and connections to be able to travel to the 
city to seek diagnosis and/or care. This is a limitation of the study but 
one that is difficult to avoid, since the vast majority of rural Kenyans 
with PD, and those with lower social/financial capital, remain undiag-
nosed and thus ‘invisible’. For this reason, we avoid generalising about 
rural-urban contrasts; essentially, the act of diagnosis, as well as sub-
sequent treatment and support, always happened in cities. 
At each clinic, the researcher identified PwP through clinic files, with 
permission and help from the staff, and invited PwP to participate. At the 
support group meetings, the researcher described the project to at-
tendees who then approached the researcher if they were interested. 
Most were eager to share their experiences, generating rich data. 
Healthcare professionals were also approached for interview at hospitals 
and clinics; interviews were conducted with three private neurologists, 
four neurologists who worked in private and public clinics, one pallia-
tive care specialist, two nurses from an urban public hospital, five reg-
istrars from an urban public hospital, five doctors from private rural 
hospitals and two doctors from public rural hospitals (Table 1). 
2.2. Data collection 
All interviews and observations were conducted by the first author 
who speaks English and Kiswahili. Participants were interviewed in 
either English or Kiswahili, according to their preference; the majority 
chose English. An additional interpreter was present for interviews 
conducted in Kiswahili to ensure accuracy of translation into English. All 
materials were translated into English prior to analysis, with a sample 
back translated, to check for consistency. 
Formal interviews and informal conversations with PwP and family 
members took a biographical approach, drawing on participant’s 
experience of life before diagnosis through to the end of life, where 
relevant, lasting 30–135 min. Informal conversations with 55 PwP 
totalled 72.5 h. Formal in-depth follow-up interviews with nine PwP 
totalled 9.5 h. In-depth semi-structured interviews with 23 family 
members and caregivers totalled 21.5 h of material. No PwP were 
present during interviews with family members, allowing them to 
discuss their experiences freely. In many cases, a family member was 
present with PwP during their interviews. Formal interviews and 
informal conversations with healthcare professionals drew on their own 
practise, knowledge of PD, experience of caring for PwP, and experience 
of private, public and alternative therapeutic landscapes, totalling 14.5 
h. All formal interviews were audio-recorded (with consent). Informal 
conversations were not audio-recorded as this risked rapport, particu-
larly with healthcare professionals who were generally busy during 
practice hours. Instead, detailed field notes were handwritten. 
Observations (165 h in total) aimed to gain an empathetic under-
standing of participants’ emotions, feelings, behaviours, experiences 
and social interactions within a culturally specific setting. Thirty-six 
hours of observations took place in public neurology clinics, and 12 h 
in private neurology clinics. Observations offered insights into groups of 
PwP with fewer resources who accessed public care and those who 
accessed private Kenyan biomedical services – private neurologists 
charged a significantly higher fee. Ethnographic observations detailed 
how people manoeuvred the clinic and negotiated challenges, their ac-
tions and emotions, the ‘system’ of the clinics, routine of events, con-
sultations, people’s interactions with neurologists and registrars, and 
interactions between patients, family members, friends and hospital 
staff. 
2.3. Ethics 
Ethical approval for the research was obtained from Kenya Medical 
Research Institute (KEMRI) and Newcastle University Research Ethics 
Committee. All participants provided written informed consent to 
participate after reading the study information sheet (in English or 
Kiswahili), or having it read to them; verbal consent was obtained for 
interviews to be audio recorded, where applicable. Oral consent for 
observations at support groups was an on-going process. However, 
informing everyone at the public clinic waiting room (typically over 200 
people) was impossible and impractical (Murphy and Dingwall, 2001). 
Approval was sought from the chief nurse, information office staff, 
nurses and neurologists in the public clinic, and receptionists and neu-
rologists in private clinics. The researcher took notes on a 
password-protected smartphone during clinics, making their presence 
less obvious and intrusive. Gorman (2016, p. 224) notes how ethnog-
raphers are increasingly using smartphones as note-taking mediums, 
where the “everyday-ness of the smartphone” creates opportunities for 
participants to feel more comfortable – a smartphone was not used 
during one-on-one conversations. 
2.4. Analysis 
Member-checking was used throughout fieldwork by returning 
analysed data to participants during support group meetings to improve 
the accuracy, validity and trustworthiness of common findings (Birt 
et al., 2016). Interview and observation data were analysed using Braun 
and Clarke’s (2006) six phases of inductive thematic analysis. This 
systematic, ‘bottom up’, reflexive approach allowed themes to be 
identified from the data, without trying to fit data into pre-existing 
categories or analytic preconceptions and maintaining the depth and 
individuality of participants’ stories. The majority of data coding and 
analysis was carried out by the first author, with 10% of interview 
material coded by a second experienced qualitative researcher who was 
not involved in the data collection. This independent analysis was done 
to ensure reliability of the coding and to check for subjectivity. 
The coding and analytical procedures were as follows. While still in 
the field, the first author transcribed all interviews and field notes, and 
read them carefully to focus data collection (Phase 1). Analysis required 
constant reviewing of interview transcripts, fieldnotes and personal re-
flections, using triangulation to test the quality of information and ac-
curacy of ethnographic material (Fetterman, 2019). After initial notes 
Table 1 
Profile of study participants.  
Participant Urban Rural Total 
PwP 39 16 55 
Family member 19 4 23 
Private healthcare professional 4 5 9 
Private & public healthcare professional 4 0 4 
Public healthcare professional 7 2 9 
Total recruited 73 27 100  
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and comments were made, Phase 2 entailed data coding and collation of 
material. In Phase 3, conceptualised empirical and theoretical codes 
were collated into main and sub-themes after iterative reviewing and 
refining by the research team (Phase 4). Themes were defined and 
named in Phase 5 and detailed analyses written, telling the story of the 
data in the final report (Phase 6). Quotations used in this paper are 
representative of wider responses. Reflexivity throughout fieldwork 
allowed the researcher to reflect on ideas and experiences, ensuring 
integrity (Arber, 2006). 
3. Results 
The study included 32 male and 23 female PwP (Table 1) with very 
different financial and social resources and living situations. Ages 
ranged from 33 to 81 years old (median age 66.5 years). Time since 
diagnosis ranged from one month to 18 years, although onset of symp-
toms usually began many years before a diagnosis. Altogether, 34 re-
spondents attended private neurology clinics in Nairobi (N = 22) and 
Mombasa (N = 12), 12 attended the public neurology clinic in Nairobi 
and nine did not attend any neurology clinic. For the reasons noted 
above, most study participants were living in urban areas; those based in 
rural settings had all travelled to cities for diagnosis/treatment and were 
thus not representative of rural Kenyans (with PD) in general. 
Thematic analysis revealed three main themes in relation to PD 
diagnosis, explored in turn below: first, the range of initial symptoms 
experienced by PwP and how these sit within expectations around 
norms of ageing and associated comorbidities; second, the complexity 
and uncertainty surrounding diagnosis and experiences of misdiagnosis; 
and third, the importance of information provision and, specifically, 
knowing the name of the condition. This section is prefaced with an 
ethnographic account of one individual – Leah – whose experiences 
serve to illustrate each theme. Pseudonyms are used throughout. 
3.1. Leah’s story 
Leah was 78-years-old and lived in the house she and her husband 
had built many years ago in rural Kenya. One of her daughters, Pauline, 
lived nearby; she looked after her parents while also running her own 
business. Her other daughter, Esther, lived and worked in Nairobi. 
Esther explained that Leah began experiencing symptoms nine years 
ago, complaining of backache and other symptoms they assumed were 
“old people problems”. Over the years, Leah’s symptoms deteriorated; she 
began to lose her voice and her pain worsened. 
After six years, Esther brought Leah to Nairobi to have her back pain 
assessed and paid for her to see a private orthopaedic doctor who, after 
hearing her speak and seeing her walk, suggested that she consult a 
neurologist, mentioning the possibility of PD. Esther tried to take Leah to 
see a private neurologist but could not get an appointment: “it was like 
the work of the receptionist to turn people away”. Instead, they asked a 
family friend who happened to be a neurosurgeon. He confirmed that 
Leah probably had PD, sent her for an MRI and prescribed PD medica-
tion. However, Esther was puzzled by the fact Leah’s memory was still 
good and she had no tremor at all. 
Back in rural Kenya, Leah visited a heart specialist for hypertension 
in a local hospital. Leah told the specialist that she was taking medica-
tion for Parkinson’s, which he questioned, noting that she “had no facial 
expression like Parkinson’s”: she was able to smile and was not shaking. 
Leah’s symptoms were being controlled by her medication, yet he 
‘cancelled’ the medicines. After Leah was effectively “un-diagnosed”, 
Esther took her to see another private neurologist in Nairobi who 
requested an MRI on her back, prescribed painkillers and confirmed the 
“un-diagnosis”. Leah went back home, took the painkillers as prescribed 
and almost died as her blood pressure dropped drastically. She then 
“abandoned” the painkillers and continued taking her hypertension 
medication. 
Two years later, Leah was unable to walk or speak; according to 
Esther, she had “wasted away”. Esther returned with Leah to Nairobi to 
see another private neurologist who asked Leah to write her name, five 
or six times, observing the micrographia and slanting of the text (key 
features of PD). On this basis, he confirmed that Leah did in fact have 
Parkinson’s and prescribed medication. However, they received no 
further information; as Esther suggested, “Five minutes in his office is too 
much” (i.e. the neurologist was unwilling to give them any more time). 
During follow-up appointments, she was cursorily examined, given a 
prescription and a date for an appointment in six months. Although 
Leah’s condition improved after resuming medication, the family felt 
they had been left on their own. Esther struggled to reconcile the 
opposing diagnoses of various ‘specialists’. 
At home, Leah continued to visit her local hospital for hypertension. 
The family had learnt to tell all the doctors they encountered about 
Leah’s Parkinson’s diagnosis. Esther said she had seen the staff ‘Goo-
gling’ the medication Leah was taking. Esther and Pauline began 
“educating” the hospital staff about PD from what they had learnt on the 
internet but felt there was nowhere to find out more about the condition, 
no one to relate to and no awareness about it in Kenya. Pauline said the 
staff were grateful for the knowledge. Esther joined a support group for 
PD in Nairobi; until then, she thought Leah was the “only Kenyan” with 
Parkinson’s. 
3.2. Recognising symptoms 
Leah’s story illustrates how people may (mis-)interpret symptoms 
when there is little or no prior awareness or knowledge of PD in Kenya. 
Distinguishing backache and “old people problems” from PD is extremely 
challenging, particularly when knowledge among healthcare pro-
fessionals is so limited, resulting in numerous misdiagnoses, even among 
specialists. The symptoms of PD are easy to confuse with those of better- 
known conditions, pre-existing comorbidities, or merely expected tra-
jectories of ageing. 
PwP often recalled their experience before diagnosis with phrases 
like: “I started feeling funny” or had “strange feelings” or “my body was not 
behaving well”. However, these aches, pains, fatigue, and slowness were 
often assumed to be part of ‘normal’ ageing, not requiring particular 
medical attention. The symptoms of PD could thus be disguised for 
years: 
“She [PwP] thought it was something normal and didn’t go to the 
doctor. She had slow movement, so thought she was just ageing” 
(Daughter of 67-year-old PwP) 
Comorbidities could further confuse and disguise the symptoms of 
PD. Bouts of dizziness and weakness or falls were often attributed to pre- 
existing diagnosed high blood pressure or low blood sugar. Others 
attributed their symptoms to other, better-known conditions like 
arthritis or stroke, which mirror some symptoms of PD. 
It was usually only when the ‘slowness’ and pain began impacting 
significantly on PwPs’ daily lives and their ability to carry out basic tasks 
(such as eating ugali (maize meal), or working) that family members 
began to suspect that something else might be wrong (Mshana et al. 
(2011) reported similar findings among PwP in Tanzania). In some 
cases, it was non-family members – friends and sometimes even 
strangers – who noticed their “strange” symptoms and convinced them 
to seek help. 
3.3. The uncertainty and complexity of obtaining a PD diagnosis 
Recognising the need to seek medical attention was, however, only 
the first part of what were almost always long, uncertain and convoluted 
journeys to diagnosis, often with several misdiagnoses along the way. 
For example, one participant had taken his mother to 16 different pri-
vate doctors before she was eventually diagnosed with PD; she had pain, 
a tremor and had begun drooling. 
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“While we were seeing him [doctor], she had a tremor, and I asked 
him, ‘What’s that?’ and he said, ‘It’s a signal from the brain’ and 
dismissed it … I thought, ‘OK it’s not serious’” (Son of 78-year-old 
PwP) 
This participant described his “relief” when his mother was finally 
diagnosed but also his “disappointment” that she had experienced so 
many misdiagnoses. Many others spent months, or years, in search of an 
accurate diagnosis. As the daughter of one 71-year-old PwP explained, 
her family were “fighting an unknown” while misdiagnoses “kept them in 
the dark” for several years. Similar cases of misdiagnosis, or lack of 
diagnosis, have been described in Ethiopia (Walga, 2019) and Tanzania 
(Mshana et al., 2011). 
For our study participants in Kenya, obtaining a diagnosis required 
not only dogged persistence, but also having sufficient funds for multiple 
consultations, scans, examinations and tests, most of which were 
available only in private-sector facilities: 
“If we didn’t have money, we would not know the problem, because 
you go to a district hospital and get referred, ten years down the line 
and you’re not seen” (Son of 69-year-old PwP) 
Even for those in better financial situations, the mounting costs often 
deterred them from pursuing a diagnosis until their symptoms worsened 
significantly. This is reminiscent of Prince’s (2018) description, also in 
Kenya, of the ‘back and forth’ that children with undiagnosed cancer 
experienced between health centres, hospitals and healers, only 
receiving a diagnosis after significant disease progression. Some PwP 
reported thinking they might die not knowing what was killing them. 
“I was almost giving up, because any time you go to the doctor, 
whatever you are getting is not helping you … The last time I went to 
that doctor, I told her “Daktari (doctor), now I’m going to die”" 
(Christine, 55-year-old PwP) 
Both patients and neurologists pointed to the limited awareness 
among non-specialist doctors as being a significant obstacle to diagnosis 
or referral to a specialist. It was acknowledged that doctors were much 
more familiar with other conditions that could produce similar symp-
toms, such as stroke or epilepsy, which they saw on a regular basis. 
Moreover, as Leah’s case demonstrates, not everyone presents with 
‘typical’ symptoms straightaway, leading sometimes to PD being ruled 
out as a diagnosis, even where there is some level of awareness of the 
condition. As a result of misdiagnoses, some PwP had reportedly been 
prescribed “unsuitable” treatment, resulting in worsening symptoms 
and/or severe medical scares. Others, who had received a PD diagnosis, 
remained uncertain and sought out second (and third) opinions from 
different specialists, withholding their previous PD diagnosis for fear 
that it may be wrong. 
In the face of these obstacles, serendipity could play a key route to 
diagnosis. For example, Frank (aged 77) had begun shaking but thought 
he was “just getting old”. A friend at his church in Mombasa also noticed 
Frank’s hand shaking and insisted he see a doctor. Similarly, in Nairobi, 
Matthew (aged 62) had a tremor in his hand, his voice had lowered, and 
speech had slowed, but he had not thought these changes required 
attention. Again, someone at his church directed him to a neurologist. In 
one case, a hospital doctor in rural Kenya happened to have some 
knowledge of PD and spotted advanced symptoms in a handful of pa-
tients who had been admitted for other conditions. In most cases, 
though, doctors in under-staffed rural government hospitals, without 
specialist training, are unlikely to pick up cases, especially less advanced 
ones; most will go unrecognised unless patients or their families have the 
wherewithal to reach a major city to see a neurologist. 
3.4. Knowledge, information and understanding of PD at diagnosis 
Participants reportedly experienced multiple barriers to gaining 
knowledge at diagnosis. Most of those attending the public clinic were 
not told the name of their condition, ‘Parkinson’s disease’. Many PwP 
described their frustration that PD had been “forgotten” while other 
diseases received more attention and publicity. 
“It’s a nuisance. It’s a constant problem … Go and talk of cancer or 
diabetes, everyone knows what it is. I feel this condition has not been 
given the time it deserves … People here don’t understand. People 
here don’t know this disease” (Paul, 70-year-old PwP) 
Several participants recalled feeling alone, “clueless” and receiving 
very little information (in both public and private facilities) during the 
diagnostic process. Some were not told that PD was progressive; the 
nephew of one PwP explained, “When we are given medicine, we just as-
sume it is for curing”. Neurologists also admitted not providing expla-
nations about prognosis. Few PwP reported being provided with any 
verbal information at diagnosis. 
Informational resources for PwP and their families were extremely 
limited, and those that existed were only available in English. Conse-
quently, some PwP were at a loss in how to understand and explain their 
condition, wondering whether it was their “brain getting rotten”, a result 
of working too hard, or a punishment from God or Satan. A few reported 
‘Googling’ PD but not all had access to the internet. The limited infor-
mation received at diagnosis has also been reported in some HICs 
(Parkinson’s Disease Society, 2008; Schrag et al., 2018). However, in 
Kenya, this was more extreme: nine of the 12 PwP recruited from the 
public clinic did not know they had PD, seriously limiting their oppor-
tunity to find out about their condition. 
Neurologists who participated in the study were asked to reflect on 
why so little information was provided with diagnosis. They readily 
admitted that, in both private and public clinics, the time spent with 
patients was limited and they were under pressure to rush through ap-
pointments. In the public clinic, the main priority was “churning out 
numbers” as one neurologist put it. Some neurologists were apparently 
reluctant to disclose a specific diagnosis because they worried that pa-
tients would then ask lots of questions that they had no time to answer. 
Neurologists were more inclined to disclose a diagnosis in private 
clinics, although additional explanations were still limited. Although 
probably more extreme, this situation is not limited to LMICs; in Europe, 
Schrag et al. (2018) identified that only 38% of 1775 PwP felt they had 
been given enough time to ask questions at diagnosis. 
Neurologists also pointed to the challenges of explaining things – 
especially in a short time-frame – to patients with lower levels of edu-
cation and English proficiency; as a result, they tended to give more 
information to those they perceived to be more capable of understanding 
it. As reported by Andersen (2004) in Ghanaian hospitals, neurologists 
"categorised" patients according to perceived educational level. Some 
admitted to becoming “different doctors” when interacting with patients 
with (apparently) lower levels of education and/or fewer resources, 
offering less information or time for questions. In some cases, neurolo-
gists justified these actions by pointing to the longer amount of time 
required to take a proper history from patients or family members who 
were less able to explain; as one neurologist put it: 
“It spills over depending on your, well, one your complexity and how 
sick you are. So, if you’re stretcher ridden … you’re there with a 
relative who has no idea, that’s going to drag out … Just trying to 
extract that information will take much longer” (Neurologist B) 
(See also Ferguson and Candib (2002); Van den Berg (2016) for other 
examples of challenges around (perceived) language proficiency and 
doctor-patient communications in Africa.) 
Some neurologists also mentioned their reluctance to deliver bad 
news as a reason for withholding a definitive diagnosis. A PD diagnosis 
was not a “positive one” as one neurologist put it. Initial treatment for PD 
typically results in an initial, immediate improvement of symptoms and 
it was difficult, said some, to take away people’s hopes of recovering by 
labelling them with a progressive disease with no cure: 
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“You know it is Parkinson’s but don’t want to put it clearly … It’s not 
going to be a curable disease, you’re going to get worse over time and 
you may get all these complications … and I think the patient also 
doesn’t want to know” (Neurologist A) 
As a result, they would often use vaguer terms and explanations: 
“something neurological”, “the shaking problem”, “the system is low”, 
“nerve issue”, and suchlike, to avoid mentioning the name ‘Parkinson’s 
disease’. This phenomenon of physicians withholding ‘bad news’ from 
patients and their families has been described in relation to cancer care 
in Kenya by Mulemi (2008). Similar considerations led some family 
members in our study to collude in this practice in order to ‘protect’ the 
PwP from despair. However, as with Mulemi (2008) study, most of our 
participants with PD wanted to know what their symptoms meant. 
Several expressed the relief that came from receiving a diagnosis, which 
helped them to make sense of previously inexplicable symptoms and 
take some control of the situation, by beginning treatment, searching for 
information and perhaps joining a support group – although, of course, 
access to these were heavily contingent on social position, connections 
and affordability. 
The consequences of not receiving a diagnostic label were manifold 
and had important consequences for PwP. It did not necessarily prevent 
them from receiving appropriate medication, if they could afford it; as 
one neurologist explained, it is quicker to write a prescription than to 
provide a detailed explanation. However, it did prevent the opportunity 
to share a diagnosis with family and friends, learn how to manage PD, 
and took away the option of accessing additional services (albeit that 
these were scarce and often unaffordable anyway). It also contributed to 
ongoing stigma associated with apparently inexplicable (and perhaps 
even supernaturally-acquired) symptoms. For example, Magnus (aged 
66) had been told by doctors at the government clinic just to “manage” 
his unnamed condition. Alone in Nairobi, Magnus felt he could not re-
turn to his village where people would assume that he was the target of 
witchcraft; as a result, he had not seen his family in years. Similarly, 
Nzambi, aged 58, had been attending the government clinic for 17 years 
for his “sickness”, and had developed severe dyskinesia. In the absence 
of a plausible explanation for these symptoms, Nzambi’s wife had 
recently left him, taking their children with her. The same happened to 
two other younger male PwPs, whose families abandoned them, fearing 
that malevolent supernatural forces were at play. 
4. Discussion 
Through the accounts presented above of PwP, their family members 
and neurologists, the reasons why so many PwP in Kenya (and probably 
other LMICs) go undiagnosed become clear. First, levels of awareness of 
PD are extremely low, even among healthcare professionals. As a result, 
symptoms are often dismissed as being a ‘normal’ part of ageing or 
associated with (diagnosed and undiagnosed) co-morbidities. Second, 
even when symptoms are identified as being problematic (usually only 
when they have become advanced), a lack of capacity and training in 
Kenya means that misdiagnosis (and even ‘un-diagnosis – reversal of a 
previous diagnosis) is common. And finally, whether because of time 
constraints, unfortunate stereotyping of certain ‘types’ of patients, or a 
well-meaning desire to protect patients from ‘bad news’, in many cases, 
neurologists fail to communicate the diagnosis to individuals and their 
family/caregivers. In a country like Kenya, where treatment for PD is 
scarce and expensive, obtaining a diagnosis is no guarantee of appro-
priate care. However, without a diagnosis, accessing information, care 
and maintaining the support of a family network become almost 
impossible. 
As well as illuminating the empirical situation on the ground in 
Kenya, the data from this study also speak to wider theoretical concerns 
emerging from the rise of chronic conditions associated with ageing in 
Africa, which we elaborate below. 
4.1. Expectations around ageing 
First, the initial step in diagnosis – recognition by the patient and/or 
those close to them that there may be ‘something wrong’ – is closely 
bound with expectations about the changes in capabilities and bodily 
functions associated with ageing. Becoming stooped, slowing down, 
being in pain and developing a slight tremor were widely regarded as 
being an inevitable and ‘normal’ part of ageing. This is not unique to 
Kenya; similar observations were made in the USA, by Solimeo (2009), 
who described how early symptoms of PD are often mistaken for 
“normal” ageing processes. 
Among our study participants, bodily changes were thought to 
require attention only when they began to impact seriously on PwPs’ 
ability to carry out important daily activities and could no longer be 
dismissed as “old people problems”. These threats to “personhood” 
(Degnen, 2018) were often therefore defining moments. Luborsky 
(1994, p. 240) has suggested that socially legitimated, full personhood is 
“earned by achieving and maintaining expected social roles and ideals”. 
Those expected roles necessarily shift over the course of a lifetime. In 
East Africa, McIntosh (2017) and Whyte (2017) have suggested that a 
decline in old age is expected and that a relationship of “desired inter-
dependence”, with elders being supported by their kin, is the ideal. 
However, as PwPs’ conditions deteriorated, they became increasingly 
dependent on others and less able to reciprocate in expected ways, 
precipitating a move to seek medical opinions/care. 
With a growing ageing population in Africa, we urgently need to 
understand more about expectations of ageing and associated social and 
political contingencies (Powell and Hendricks, 2009). In particular, we 
need to understand why many people in SSA may expect to have some 
form of disability as they age (Sagner, 2002), and to what extent this is 
associated with the limited diagnosis and treatment of many chronic 
conditions (including PD). 
4.2. Uncertainty and agency 
Uncertainty in the diagnostic journey for our study participants was 
multifaceted and took on different forms and depths: it was evident from 
the onset of symptoms, during initial consultations and even after 
diagnosis, when the lack of definitive clinical tests to confirm PD meant 
that diagnosis could later be questioned or even reversed. This contrasts 
with the “digital certainty” Whyte (2014) talks of regarding HIV testing 
in Uganda, as well as the apparent objectivity of “numbers” associated 
with diabetes and hypertension. 
To some extent, diagnostic uncertainty thus results from character-
istics of the disease itself (lack of specificity in symptoms and diagnostic 
tests) and of an underdeveloped and often unreliable biomedical health 
system. However, uncertainty is also produced whereby information is 
(sometimes deliberately) withheld from patients and caregivers, 
because of time constraints during consultations, assumptions on the 
part of clinicians about patients’ educational and social positions, or a 
desire to avoid communicating disheartening news about an incurable 
degenerative condition. Uncertainty thus does important work, poten-
tially helping to maintain ‘hope’ in the face of a grim prognosis, but also 
serving perhaps to undermine the agency of patients to seek care, live 
well, gain legitimacy and form sociality around their condition. 
While our study participants varied considerably in their reactions to 
diagnosis, for the most part, uncertainty and lack of information were 
associated with heightened fear rather than hope, echoing findings by 
Selman et al. (2009) on the needs of patients with incurable progressive 
diseases in Uganda and South Africa. However, the agency conferred by 
diagnostic certainty was nonetheless still limited by the lack of available 
treatment options for PwP living in Kenya. 
4.3. Naming and legitimacy 
One important consequence of not knowing the name of their 
N. Fothergill-Misbah et al.                                                                                                                                                                                                                    
Social Science & Medicine 282 (2021) 114148
7
condition was the social stigma associated with uncanny symptoms that 
were not legitimised with a diagnostic label. Naming symptoms as a 
diagnosis has been described as crucial in the social construct of disease 
(Fleischman, 1999), enabling those affected to be socially “normalised” 
(Jutel, 2011) and enjoy a form of “biolegitimacy” (Fassin, 2009, p. 52). 
Writing about HIV/AIDS in South Africa, Fassin proposed that acquiring 
a diagnostic label opens up possibilities for making claims to treatment 
and care through forms of “biological citizenship” or “therapeutic citi-
zenship” (Rose and Novas, 2007; Nguyen et al., 2010; Marsland, 2012). 
Subsequent work on therapeutic citizenship in sub-Saharan Africa 
has also focussed predominantly on HIV/AIDS and access to life-saving 
anti-retroviral therapy (ART) which, especially in the early days, was 
available largely through trials and non-governmental organisations. 
Crucially, access to treatment, which was highly politicised, depended 
absolutely not just on getting a diagnosis but on being able to use that 
diagnosis to make claims for medication in the context of a highly- 
fragmented and contingent treatment landscape (Nguyen et al., 2010; 
Whyte, 2012). . 
By contrast, PD has remained politically and socially invisible in 
Kenya and indeed across the African continent. Unlike HIV/AIDS, 
receiving a diagnostic label for PD does not offer a clear pathway to 
making ‘citizen-like’ claims to treatment for the vast majority of Ken-
yans who cannot afford fees for expensive private clinics and medication 
and who lack the necessary social connections (what Whyte (2014) 
called ‘technical know-who’) to access services (see also Marsland 
(2012)). However, it could, in some cases, enable participants to access 
(albeit limited) information and support, plan for their future, and have 
their suffering legitimised, for themselves and others. Since the end of 
fieldwork, a new material benefit has also emerged: PwP in Kenya can 
now register with the National Council for Persons with Disabilities, 
entitling members to tax exemptions, state allowances and tax-free 
disability aids (Republic Of Kenya, 2019), although the take-up and 
impact of this initiative has yet to be seen. 
5. Conclusion 
This research has contributed to the very limited understanding 
about the experience of Parkinson’s disease in sub-Saharan Africa, 
through exploring PwPs’ diagnostic journeys in Kenya. Participants 
acknowledged their symptoms as ‘abnormal’ through a threat to 
personhood and desired interdependence, while constantly negotiating 
the deep and multifaceted uncertainty surrounding PD, and the limits of 
biolegitimacy. PD, in the context of Kenya and likely other low-resource 
settings, differs from conditions which have been the object of political 
organisation (for example, HIV). Knowing the name ‘Parkinson’s dis-
ease’ does not automatically provide access to claims, services, or 
treatment; however, giving a name to symptoms and suffering had 
important social implications and allowed PwP to justify their illness to 
themselves, family, friends, and society. Diagnostic labels can help to 
increase the social and political visibility of a condition like PD that 
remains largely off-radar in terms of government and donor support. 
Improving PD awareness would not only assist with ensuring early 
recognition of symptoms, timely diagnosis, and – if available – the 
commencement of appropriate treatment; it would also reduce the 
substantial costs associated with referrals and misdiagnoses, while 
challenging stigmatising perceptions within communities. However, 
with the low number of neurologists, largely unaffordable private con-
sultations, and overwhelmed public clinics, access to effective treatment 
remains very limited for most Kenyans, particularly perhaps for rural 
populations without urban networks and the resources required to travel 
to the city. In other words, reliable and timely diagnosis is just the 
starting point; it is a necessary but not a sufficient condition for effective 
treatment. This next step is beyond the scope of the current paper, but 
there has been some promising work around developing low-cost PD 
treatment in Africa using Mucuna pruriens, a levodopa-containing legu-
minous plant that has demonstrated encouraging results in on-going 
trials (Cilia et al., 2018; Fothergill-Misbah et al., 2020b). However, 
technological innovation will need to be accompanied by significant, 
joined-up healthcare investment and increased prioritising of geriatric 
care to achieve tangible results at a larger scale. 
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